It's a rebuilding year for the medical device maker.
News & Analysis: Natus Medical
BABY earnings call for the period ending March 31 2019.
Most biotech drugs focus on clearing plaques from brain cells, but restoring patients' sleep quality is also proving to be necessary.
It wasn't just lower-than-expected earnings that hurt the medical device company.
2019 will be a rebuilding year for the neurology and newborn-care specialist.
BABY earnings call for the period ending December 31, 2018.
The company's softer-than-expected outlook wasn't what investors wanted to see.
Another lackluster quarter, but the medical device maker is trying to turn things around.
BABY earnings call for the period ending September 30, 2018.
After its recent turmoil, investors will take it.